IGR Anti-Obesity Prescription Drugs Market Haga clic para leer
  • Comentarios

IGR

Anti-Obesity Prescription Drugs Market

Publicado el en “Salud y Estado Físico, Negocios”, Idioma — English. 4 páginas.
The report on Anti-Obesity Prescription Drugs Market by drug class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), distribution channel (retail pharmacy, hospital pharmacy and online pharmacy), age group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Más

Otras publicaciones de “IGR”

Ver todas las publicaciones